| Brian D Monette, MD | |
|
1112 E Ascension Complex Ave., Gonzales, LA 70737 | |
| (225) 921-5770 | |
| (225) 644-5168 |
| Full Name | Brian D Monette |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 28 Years |
| Location | 1112 E Ascension Complex Ave., Gonzales, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699781591 | NPI | - | NPPES |
| 1480789 | Medicaid | LA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prevost Memorial Hospital | Donaldsonville, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Area Human Services District | 2769450733 | 25 |
News Archive
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company's portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.
› Verified 4 days ago
| Entity Name | Capital Area Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174681852 PECOS PAC ID: 2769450733 Enrollment ID: O20081118000007 |
News Archive
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company's portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.
› Verified 4 days ago
| Entity Name | Capital Area Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710047980 PECOS PAC ID: 2769450733 Enrollment ID: O20081118000023 |
News Archive
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company's portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.
› Verified 4 days ago
| Entity Name | Capital Area Human Services District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730104654 PECOS PAC ID: 2769450733 Enrollment ID: O20100114000532 |
News Archive
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company's portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian D Monette, MD P.o. Box 1725, Gonzales, LA 70107-1725 Ph: (225) 621-5770 | Brian D Monette, MD 1112 E Ascension Complex Ave., Gonzales, LA 70737 Ph: (225) 921-5770 |
News Archive
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection. Although most progress quickly from initial infection to immunodeficiency, a small subset survive for long periods without developing symptoms.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA (exenatide twice-daily) as an add-on therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected.
DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company's portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.
› Verified 4 days ago
Lance Everett Bullock, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3136 S Saint Landry Ave, Gonzales, LA 70737 Phone: 225-647-7524 | |
Dr. Amer M. Awad, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2647 S Saint Elizabeth Blvd, Suite 225, Gonzales, LA 70737 Phone: 225-647-8511 Fax: 225-644-4206 | |
Dr. Rodney E Hillis, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2647 S Saint Elizabeth Blvd, Gonzales, LA 70737 Phone: 225-647-8511 Fax: 225-644-5213 | |
Dr. Chris T Trevino, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 41229 Highway 941, Gonzales, LA 70737 Phone: 225-806-3397 Fax: 225-644-1423 | |
David E Post, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1112 E Ascension Complex Blvd, Gonzales, LA 70737 Phone: 225-621-5770 Fax: 225-644-3208 | |
Dr. Mitchell Lee Rodeheaver, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1112 E Ascension Complex Blvd, Gonzales, LA 70737 Phone: 225-450-1016 Fax: 225-450-1150 |